Osaka, Japan

Stephan D Parent

This inventor holds 1 USPTO granted patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephan D Parent. Retrieved from https://idiyas.com/inventor/stephan-d-parent-8jqzjib9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephan D. Parent

Introduction

Stephan D. Parent is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with specific receptors in the body. His work is characterized by a focus on innovative drug substances that have the potential to improve health outcomes.

Latest Patents

Stephan D. Parent holds 1 patent for his invention titled "Salt and crystal form of compound having agonistic activity to S1P5 receptor." This patent describes Compound I, which exhibits high S1P receptor-selective agonist activity. The invention includes the crystal forms of Compound I, the salts of Compound I, and the crystal forms of salts thereof, which are provided as drug substances for pharmaceuticals.

Career Highlights

Stephan D. Parent is currently employed at Ono Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His work at Ono has allowed him to focus on innovative research and development, contributing to the advancement of medical science.

Collaborations

Throughout his career, Stephan has collaborated with talented individuals such as Shuhei Otani and Takayuki Fujito. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the pharmaceutical field.

Conclusion

Stephan D. Parent's contributions to the field of pharmaceuticals through his innovative patent and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic options that can benefit patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…